Panagora Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Panagora Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,202	Closed	-$64K	–	2450
2016 Q1	$64K	Hold	1,202	–	–	﹤0.01%	1972
2015 Q4	$136K	Sell	1,202 -1,479	-55%	-$163K	﹤0.01%	1707
2015 Q3	$316K	Sell	2,681 -6,238	-70%	-$815K	﹤0.01%	1462
2015 Q2	$691K	Buy	8,919 +7,831	+720%	+$513K	﹤0.01%	1234
2015 Q1	$63K	Buy	+1,088	New	+$46.2K	﹤0.01%	2043

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Panagora Asset Management's ANAC Position: Q2 2016 in Review

Panagora Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,202 shares — an estimated $64K sold.

Panagora Asset Management first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $691K in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Panagora Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Panagora Asset Management sold 1,202 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $64K.
Panagora Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Panagora Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $691K in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Panagora Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.